TFCP2L1 and renal cell carcinoma: Jin et al. reported that tumor-derived extracellular vesicles promote renal cell carcinoma invasion and metastasis by transferring MALAT1 facilitating the binding of ETS1 and the TFCP2L1 promoter [48].